Daiwa Securities Group’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Sell |
535
-30,290
| -98% | -$56.6K | ﹤0.01% | 1242 |
|
|
2025
Q1 | $45K | Sell |
30,825
-1,106
| -3% | -$1.62K | ﹤0.01% | 1028 |
|
|
2024
Q4 | $68K | Buy |
31,931
+6,590
| +26% | +$14K | ﹤0.01% | 1025 |
|
|
2024
Q3 | $71K | Sell |
25,341
-1,019
| -4% | -$2.86K | ﹤0.01% | 1034 |
|
|
2024
Q2 | $61K | Sell |
26,360
-4,178
| -14% | -$9.67K | ﹤0.01% | 1073 |
|
|
2024
Q1 | $137K | Sell |
30,538
-1,960
| -6% | -$8.79K | ﹤0.01% | 1026 |
|
|
2023
Q4 | $104K | Buy |
32,498
+17,471
| +116% | +$55.9K | ﹤0.01% | 1005 |
|
|
2023
Q3 | $48K | Hold |
15,027
| – | – | ﹤0.01% | 1057 |
|
|
2023
Q2 | $75K | Buy |
15,027
+14,492
| +2,709% | +$72.3K | ﹤0.01% | 1044 |
|
|
2023
Q1 | $3K | Hold |
535
| – | – | ﹤0.01% | 1165 |
|
|
2022
Q4 | $3K | Hold |
535
| – | – | ﹤0.01% | 1177 |
|
|
2022
Q3 | $6K | Hold |
535
| – | – | ﹤0.01% | 1145 |
|
|
2022
Q2 | $6K | Buy |
535
+119
| +29% | +$1.34K | ﹤0.01% | 1147 |
|
|
2022
Q1 | $4K | Hold |
416
| – | – | ﹤0.01% | 1179 |
|
|
2021
Q4 | $6K | Sell |
416
-71
| -15% | -$1.02K | ﹤0.01% | 1171 |
|
|
2021
Q3 | $13K | Buy |
487
+208
| +75% | +$5.55K | ﹤0.01% | 1117 |
|
|
2021
Q2 | $7K | Hold |
279
| – | – | ﹤0.01% | 1053 |
|
|
2021
Q1 | $10K | Buy |
279
+15
| +6% | +$538 | ﹤0.01% | 1044 |
|
|
2020
Q4 | $7K | Sell |
264
-523
| -66% | -$13.9K | ﹤0.01% | 1031 |
|
|
2020
Q3 | $30K | Buy |
787
+99
| +14% | +$3.77K | ﹤0.01% | 958 |
|
|
2020
Q2 | $13K | Hold |
688
| – | – | ﹤0.01% | 1035 |
|
|
2020
Q1 | $13K | Hold |
688
| – | – | ﹤0.01% | 1028 |
|
|
2019
Q4 | $18K | Buy |
+688
| New | +$18K | ﹤0.01% | 1010 |
|